The Nuvalent acquisition is the biggest biopharma deal of the week — and it's rewriting the playbook for lung cancer…
Day: June 11, 2026
CRWD Just Beat, Split, and Rallied. Now What Does the Options Market Actually Say?
CrowdStrike's 4-for-1 stock split and record Q1 FY2027 results set up a complex options landscape heading into July.